These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32366931)

  • 1. IFN-γ and IgG responses to Mycobacterium tuberculosis latency antigen Rv2626c differentiate remote from recent tuberculosis infection.
    Amiano NO; Morelli MP; Pellegrini JM; Tateosian NL; Rolandelli A; Seery V; Castello FA; Gallego C; Armitano R; Stupka J; Erschen MA; Ciallella LM; de Casado GC; Cusmano L; Palmero DJ; Iovanna JL; García VE
    Sci Rep; 2020 May; 10(1):7472. PubMed ID: 32366931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.
    Peña D; Rovetta AI; Hernández Del Pino RE; Amiano NO; Pasquinelli V; Pellegrini JM; Tateosian NL; Rolandelli A; Gutierrez M; Musella RM; Palmero DJ; Gherardi MM; Iovanna J; Chuluyan HE; García VE
    EBioMedicine; 2015 Aug; 2(8):884-90. PubMed ID: 26425695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-Hit
    Adankwah E; Lundtoft C; Güler A; Franken KLMC; Ottenhoff THM; Mayatepek E; Owusu-Dabo E; Phillips RO; Nausch N; Jacobsen M
    Front Immunol; 2019; 10():1518. PubMed ID: 31333654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis - The most suitable surrogate biomarker for latent TB infection.
    Prabhavathi M; Pathakumari B; Raja A
    J Infect; 2015 Aug; 71(2):238-49. PubMed ID: 25936741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.
    Kobashi Y; Shimizu H; Ohue Y; Mouri K; Obase Y; Miyashita N; Oka M
    Lung; 2010 Aug; 188(4):283-7. PubMed ID: 20422203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection.
    Goletti D; Butera O; Vanini V; Lauria FN; Lange C; Franken KL; Angeletti C; Ottenhoff TH; Girardi E
    Eur Respir J; 2010 Jul; 36(1):135-42. PubMed ID: 19926735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-IFNγ Whole Blood Cytokine Responses to Mycobacterium tuberculosis Antigens in HIV-exposed Infants.
    Anterasian C; Warr AJ; Lacourse SM; Kinuthia J; Richardson BA; Nguyen FK; Matemo D; Maleche-Obimbo E; John Stewart GC; Hawn TR
    Pediatr Infect Dis J; 2021 Oct; 40(10):922-929. PubMed ID: 34525006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the QuantiFERON?-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand.
    Reechaipichitkul W; Pimrin W; Bourpoern J; Prompinij S; Faksri K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):236-44. PubMed ID: 26342121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline QuantiFERON results and the distinction between specific responses and test variability.
    Uzorka JW; Bossink AWJ; Franken WPJ; Thijsen SFT; Leyten EMS; van Haeften AC; Doornenbal G; Boonstra P; Ottenhoff THM; Arend SM
    Tuberculosis (Edinb); 2018 Jul; 111():102-108. PubMed ID: 30029893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
    Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
    Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
    Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
    Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.